This is not the most recent version of the article. View current version (20 SEP 2016)

Intervention Review

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

  1. Peter C Gøtzsche*,
  2. Helle Krogh Johansen

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 7 JUL 2010

Assessed as up-to-date: 6 JAN 2010

DOI: 10.1002/14651858.CD007851.pub2


How to Cite

Gøtzsche PC, Johansen HK. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD007851. DOI: 10.1002/14651858.CD007851.pub2.

Author Information

  1. Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

*Peter C Gøtzsche, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 3343, Copenhagen, DK-2100, Denmark. pcg@cochrane.dk.

Publication History

  1. Publication Status: Edited (no change to conclusions), comment added to review
  2. Published Online: 7 JUL 2010

SEARCH

This is not the most recent version of the article. View current version (20 SEP 2016)

  1. You have free access to this content

Previous versions of this article and their online publication dates

  1. Version 1

    Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

    Peter C Gøtzsche, Helle Krogh Johansen and Asger Dirksen

    Version of Record online: 15 APR 2009 | DOI: 10.1002/14651858.CD007851